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Electrostatic sub-micron complexes of a protein (sodium caseinate (NaCAS) or bovine serum albumin
(BSA)) and a polysaccharide (chitosan) were fabricated by associative phase separation and investigated
for use in encapsulation and pH-triggered delivery applications. Various factors have been studied with
respect to the extent of complexing and the size and morphology of the complexes produced, including
protein type and the biopolymer mixing ratio. The effect of applying ultrasound has been considered
with a view to comminuting precipitates produced under low shear to the colloidal scale to form co-
acervates. A simple model is suggested to explain how the biopolymer mixing ratio inﬂuences the ability
for application of ultrasound to convert macroscopically phase-separated complex precipitates into co-
acervates. Different factors, both from a formulation and processing viewpoint, were studied with
respect to encapsulation efﬁciency (EE) of model hydrophilic actives: ﬂuorescein, rhodamine B, and
riboﬂavin. Release of ﬂuorescein and rhodamine B was measured as function of pH in order to investigate
the pH-responsive molecular release capability of the fabricated structures. It is envisaged this work will
add to the current tool-box of pH-responsive molecular delivery approaches, including those in the areas
of foods, pharmaceuticals, and agrochemicals.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Proteins and polysaccharides are polymers ubiquitous in nature.
Research into how they interact, in addition to their behaviours at
surfaces and interfaces, has long been undertaken (Dickinson,
2006; Rodríguez Patino & Pilosof, 2011). Due to the diverse range
of chemical functionalities available, biopolymers can be assembledr Ltd. This is an open access articlinto supramolecular structures held together by interbiopolymer
forces. Controlling the type and relative magnitude of these forces
enables production of a wide range of material properties, and
potentially, the prospect of physically compartmentalising com-
pounds (i.e. functional ingredient encapsulation), a feature often
considered desirable for functional food, pharmaceutical, and
agrochemical formulation design (Chen, Remondetto, & Subirade,
2006; Hack et al. 2012; Madene, Jacquot, Scher, & Desobry, 2006).
In a binary biopolymer system containing a protein and poly-
saccharide, the net interaction between the biopolymers can bee under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the precise structures of the biopolymers present and the prevail-
ing conditions, i.e. pH, ionic strength, and mixing conditions
(Dickinson, 1998; Syrbe, Bauer, & Klostermeyer, 1998; Tolstoguzov,
1991). Whilst it is recognised that such interactions impart many of
the functional properties of foods, further research is required to
develop uses in encapsulation and targeted delivery of active in-
gredients. “Active ingredients” in the broadest sense include crop
protection products, pharmaceuticals, and nutrients.
One way to encapsulate functional molecules in protein-
polysaccharide complexes involves ‘bottom-up’ self-assembly of
the constituent biopolymers. If an active is included during or after
complex assembly it can become entrappeddphysically or chem-
icallydwithin the biopolymer matrix. When the biopolymers
contain ionising groups, such as those found on polypeptide side
chains and polysaccharides, an electrostatic force predominates
that holds the newly-formed complex together; complexes pro-
duced in this way have potential application as pH-responsive
materials that can assemble and dissociate under pH control.
From a green and sustainable design viewpoint, biopolymers often
have good biocompatibility and toxicity proﬁles, in addition to
being derived from under-utilised resources; transition to use of
sustainable materials may reduce the dependency on
petrochemical-derived synthetic materials often used in non-food
applications (Doi, Clark, Macquarrie, & Milkowski, 2002).
In this study we focus on using chitosan and protein as
biopolymer building blocks for complex formation. Chitosan, a
polysaccharide derived from crustaceans (e.g. crab shells) has
received attention for use in pharmaceutical/biomedical applica-
tions (Bugamelli, Raggi, Orienti, & Zecchi, 1998; Qin, Zhu, Chen, &
Zhong, 2007), and increasingly, for food neutraceutical encapsula-
tion (Chen et al. 2006), in addition to emulsion interfacial structure
development (Ogawa, Decker, & McClements, 2003, 2004); more
broadly, chitosan is regarded as a sustainable material with appli-
cations ranging from catalysis to water puriﬁcation (Macquarrie &
Hardy, 2005). The versatility and uniqueness of chitosan origi-
nates in its chemical structure: the preponderance of amine groups
on the polysaccharide backbone makes it the only naturally-
derived cationic biopolymer. Protonation of these amine groups
enables chitosan to be solubilised and easily manipulated in mildly
acidic conditions (e.g. dilute acetic acid). Chitosan's chemical
structure is also responsible for its mucoadhesive property (Sogias,
Williams, & Khutoryanskiy, 2008; Sogias, Williams, &
Khutoryanskiy, 2012), which has been considered in various drug
delivery contexts.
Although chitosan has not been marketed in any drug products,
it has received attention for possible applications in drug delivery,
muco-adhesive dosage forms, rapid release forms, improved pep-
tide delivery, colonic drug delivery systems and for gene delivery
(Baldrick, 2010). Human exposure to chitosan has occurred, though
not in pharmaceutical application, through dietary supplements
designed for treating obesity and hypercholesterolaemia. For foods,
chitosan has been designated as: Generally Recognised as Safe
(GRAS) in the USA; it is listed as a food additive in Japan, Finland,
and Italy (Baldrick, 2010).
In comparison to polysaccharides it is well known that proteins
differ both in structure and function. Caseins and related caseinates,
which are naturally occurring milk proteins, are often used in food
products as emulsifying agents for stabilisation of emulsions and
foams; this contrasts with the majority of polysaccharides,
including chitosan, which have minimal surface activity, and as
such, are mainly used for rheology-control and/or water-holding
(Dickinson, 2009). Sodium caseinate (NaCAS), which is typically
produced from acid casein, is principally comprised of four water-
soluble caseins (as1, as2, b, and k) assembled together. Whilst asigniﬁcant body of research has been generated to understand how
NaCAS adsorbs at surfaces and interfaces, focus has recently shifted
to its use as a biocompatible, non-toxic nano-carrier for encapsu-
lation of vitamins and neutraceuticals (Semo, Kesselman, Danino,&
Livney, 2007). Other research articles have demonstrated that
chitosan forms complexes with a wide range of both globular and
‘disordered’ proteins (Anal, Tobiassen, Flanagan, & Singh, 2008;
Huang, Sun, Xiao, & Yang, 2012; Lee & Hong, 2009; Yu, Hu, Pan,
Yao, & Jiang, 2006). One of earliest studies investigated the pre-
cipitation of casein directly from milk for potential use in cheese
making (Ausar et al. 2001). However, additional studies are
required to develop complexes that enable pH-modulated delivery
of functional molecules. This approach has a number of useful ap-
plications across foods, pharmaceuticals and agrochemicals.
To this end, the ﬁrst part of this work investigates the
complexation of chitosan and two proteins e sodium caseinate
(NaCAS) or bovine serum albumin (BSA) e to evaluate how protein
type inﬂuences the extent of complexing and the type of complexes
produced (i.e. soluble versus insoluble complexes (precipitates or
coacervates?)). BSA and NaCAS differ markedly in structure, with
NaCAS being amorphous (Kontogiorgos, Ritzoulis, Biliaderis, &
Kasapis, 2006) and BSA being globular crystalline (Ikeda &
Nishinari, 2001). We consider how these differences in structure
affect the extent of complexing and type of complexes produced
under comparable processing and solution conditions.
Recently, ultrasound has been promoted as a possible route for
modifying the functional properties of biopolymers (O'Sullivan,
Arellano, Pichot, & Norton, 2014). The effect that ultrasound has
on a molecule/polymer is related to the applied cavitation (rapid
formation and collapse of bubbles) generated by localized changes
in pressure and temperature. Most work in this area has been
directed towards investigating ultrasound processing of single a
biopolymer in solution or suspension. In particular, O'Sullivan et al.
have noted that the effect of ultrasound on the functional proper-
ties of various food proteins leads to contradictory understanding,
especially with regard to whether it can reduce protein molecular
weight (O'Sullivan et al., 2014). It has been reported that ultrasound
can reduce the molecular weight of chitosan, whilst not affecting
the degree of acetylation (Wu, Zivanovic, Hayes, & Weiss, 2008).
The effect of applying ultrasound to preformed mixed protein-
polysaccharide complexes has received much less, if any, atten-
tion, although the effect of applying it to a kappa-carrageenan
(solution) prior to complexing with a protein has previously been
studied (Hosseini et al. 2013). In this work, we investigate the
impact of applying ultrasound to pre-formed insoluble macro-
scopically phase separated protein-chitosan complexes initially
formed under low shear.
Soft particles at the colloidal scale (e.g. coacervates) are poten-
tially more useful than larger complexes/precipitates for encapsu-
lation/controlled release application, as they are more stable to
sedimentation, as well as possessing a greater surface area for
molecular delivery of the encapsulated active. Furthermore,
biopolymer complex colloidal suspensions (coacervates) often have
similar rheological properties to oil-in-water emulsions which
mean they could potentially be included within such products for
controlled active or nutrient delivery.
The second part of the work goes on to demonstrate the po-
tential for, and investigate some of the parameters that affect, the
ability for various model active compounds to be encapsulated
during mixed protein-chitosan complex formation. Typical
formulation and processing parameters are considered in order to
probe parameters that could potentially impact on encapsulation
efﬁciency (EE). pH changes are then considered with respect to a
triggering mechanism for release of the encapsulated active. It is
envisaged that the information generated in this work will be
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contributing to the design of new formulations across other sectors
(e.g. agrochemicals, pharmaceuticals, etc) which could beneﬁt from
the pH-modulated delivery functionality. Typical examples of pH-
modulated delivery include protection and/or triggered release of
the active payload at different sites within the human gastroin-
testinal tract (pharmaceuticals, foods) or to different parts of the
ecosystem (agrochemicals).2. Experimental
2.1. Materials
BSA (lyophilised powder, 96% purity); NaCAS (CAS: 9005-46-
3); acetic acid (99.7% purity); low molecular chitosan (MW:
50e190 kDa) with de-acetylation degree of >75%; ﬂuorescein so-
dium salt (FSS) (CAS: 518-47-8); rhodamine B (Rhod B (CAS: 81-88-
9)); and riboﬂavin (CAS: 83-88-5) were obtained from Sigma
Aldrich, UK. All materials were used directly from themanufacturer
without further puriﬁcation. All water used in this study was
passed through a double-distillation column equipped with a de-
ionisation unit.2.2. Methods
2.2.1. Protein-chitosan complex preparation without encapsulated
actives
A stock solution of 1% protein (either NaCAS or BSA) was pre-
pared under stirring by dissolving the desired amount of protein
into 30 mM sodium acetate buffer at pH 5; this solution was left to
stir for ca. 2 h. At pH 5 NaCAS existed partly as dewatered particles
(this will be explained more fully in the results and discussion
section). A BSA solution at the same concentration and pH was
transparent indicating higher protein solubility. A separate stock
solution (1% chitosan, 2% acetic acid, 97% water) was prepared
under stirring until complete hydration of the polysaccharide. The
pH of this solution was ca. 3. For a set of experiments a proportion
of this stock chitosan solution was adjusted under vigorous stirring
to pH 5 with 10% sodium hydroxide (NaOH).
All protein-chitosan mixtures were deﬁned by total biopolymer
concentration (TBC), mass proportion of total biopolymer present
that is protein (Mprotein), and mass proportion of total biopolymer
present that is chitosan (Mchit). TBC inwt%, MChit, andMprotein in the
suspensions were deﬁned by equations [1], [2], and [3]:
TBC ¼ mchit Cchit þ mprotein C protein
Ts
(1)
Mchit ¼
mchit Cchit
Ts
(2)
Mprotein ¼ 1Mchit (3)
where mchit is the mass in g of chit stock solution of concentration
Cchit (wt%), mprotein is the mass (g) of protein solution of concen-
tration Cprotein (wt%), and Ts is the total mass of suspension. Ts of
suspensionwas ﬁxed at 50 g. As an example, to make a TBC of 2% at
a Mchit ¼ 0.25 required mixing 37.5 g of 2% protein solution at pH 5
(as in preparation of stock solution described above) with 12.5 g of
2% chitosan solution at pH 5 (as in stock solution preparation as
described above). Similarly, a suspension containing the same ratio
of biopolymers but at 1% TBCwas produced in the samemanner but
starting with 1% stock solutions of both protein and chitosan.
NaCAS-chitosan insoluble complexes were formed spontaneouslyby addition of the correct amount of chitosan solution at pH 5 to
NaCAS stock solution (pH 5) under low shear (i.e. on a magnetic
stirrer) to make the desired TBC, Mchit, and Mprotein. These sus-
pensions were subjected to ultrasonic processing (Viber Cell 750,
Sonics, USA) using a 12 mm diameter probe for 2 min (20 kHz, 95%
amplitude).
Insoluble BSA-chitosan complexes were formed by heating
mixtures under low shear containing the desired TBC, Mchit, and
Mprotein to 90 C and then cooling in an ice bath to ambient tem-
perature. After cooling, these suspensions were subjected ultra-
sonic processing (Viber Cell 750, Sonics, USA) using a 12 mm
diameter probe for 2 min (20 kHz, 95% amplitude), in the sameway
as for the NaCAS-chitosan complexes described previously.
2.2.2. Particle size analysis
z-average particle diameter (also known as the hydrodynamic
diameter) of the resulting complexes was obtained by dynamic
light scattering (DLS) using the Zetasizer Nano Series (Nano ZS)
(Malvern, UK). Two drops of concentrated protein-chitosan com-
plex suspension were diluted into 25 g 30 mM sodium acetate
buffer at original suspension pH (pH 5); this was immediately
transferred to a polystyrene cuvette and measured.
2.2.3. Zeta potential
Zeta-potential analyses were performed on the Zetasizer Nano
Series (Nano ZS) equipped with MPT-2 multipurpose titrator
(Malvern, UK). For zeta-potential measurements of complexes
made at varying Mchit, the given suspensions were diluted in the
same way as for size analyses and added to a specialized zeta cell
(Malvern, UK). Zeta potentials were reported for triplicate readings
of three freshly prepared samples.
2.2.4. Turbidity titration for BSA-chitosan complexation
BSA-chitosan soluble complex formationwas monitored using a
turbidity titration. 45 g of 0.5% BSA solution was titrated with 0.5%
chitosan solution incrementally. This was performed at pH 3, 5, and
6. 1 mL aliquots of the solution were taken after each addition of
chitosan and the solution absorbance was immediately measured
using ultravioletevisible (UV-VIS) spectrometer (Libra S12, Bio-
chrom, UK) at 420 nm. Selected solutions were stored under
quiescent conditions after being partially titrated at ambient tem-
perature, and their absorbance changes monitored over time; this
gave an indication of BSA-chitosan complex stability.
2.2.5. Microscopy
Selected suspensions (in particular those containing large
protein-chitosan precipitates) were analysed by optical microscopy
(Brunel Microscopes Ltd SP300F, UK) equipped with a camera
(Canon EOS 1000D, Japan). A drop of suspension was placed on a
glass slide with a cover slip and then analysed. This suspension
after sonication was visualised using a Phillips XL30 FEG Cryo
Scanning Electron Microscope equipped with a Gatan low tem-
perature unit. A single drop of suspensionwas placed on an analysis
slide and dipped into nitrogen at 198 C. This slide was then
inserted directly into a preparation chamber at 180 C where it
was fractured and subsequently etched for 5 min at 90 C to
minimize ice formation. The surface was coated in gold and then
imaged in the SEM at 130 C.
2.2.6. Encapsulation of model actives
Encapsulation of model activesdﬂuorescein (FSS), rhodamine B
(Rhod B), and riboﬂavin (Ribo)dwas investigated. Chemical struc-
tures of these actives are provided in Table 1.
The encapsulation of FSS was studied at varying TBC (0.25, 0.5, 1,
and 2%) and pH (5 and 7) as well as varying Mchit and Mprotein.
Table 1
Model hydrophilic actives used.
Active Chemical structure
Fluorescein
Rhodamine B
Riboﬂavin
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and at pH 5 to serve as a comparison with FSS. To perform the
encapsulation, a solution of active was separately prepared in a
30 mM sodium acetate solution (adjusted to pH 5 or 7). The con-
centration of this active solution was ﬁxed across all experiments
and chosen to enable accurate analysis by UV-VIS without addi-
tional dilution steps (i.e. this concentration at the upper end of the
concentration versus absorbance linear range). The stock concen-
trations used for eachmodel activewere as follows: FSS: 0.2mg g1,
Rhod B: 0.007 mg g1, and Ribo: 0.05 mg g1. Solutions of protein
and chitosan biopolymers at the desired TBC were separately pre-
pared as described previously and adjusted to the desired pH (pH 5
or 7) using 10 wt% HCl or NaOH. 5.5 g of the stock active solution
was added to the protein solution before complexation. The desired
amount of chitosan solution was then added drop-wise to the
protein plus active solution under stirring. This suspension was
subjected to ultrasonic processing (Viber Cell 750, Sonics, USA)
under the same conditions as described previously.
Encapsulation efﬁciency (EE) in % was determined for the
complexes by transferring 1.5 mL of suspension before and after
sonication to separate Eppendorf tubes and centrifuging (Sigma
3k30, SciQuip, UK) for 60 min at 15,000 rpm (20 C); this centri-
fugation time was determined in preliminary experiments as suf-
ﬁcient to separate the complexes as an insoluble pellet at the
bottom of the Eppendorf tube. The supernatant was analysed by
UV-VIS (Libra S12, Biochrom, UK) at the following wavelengths for
each active: FSS ¼ 460 nm, Rhod B ¼ 550 nm, and Ribo ¼ 460 nm.
Using Beer's law the concentration of active in the supernatant was
calculated over its linear range by calibration. EE was then calcu-
lated using equation [4]:
EE ¼

1 Csup
Cmax

100 (4)
where Csup is the concentration of active in the supernatant after
centrifugation and Cmax is the total concentration of active intro-
duced into the system.
2.2.7. Release studies
Release of FSS and Rhod B from the complexes was monitored as
a function of pH with a glass pH probe and meter (SevenEasy,
Mettler Toledo, Switzerland) at a ﬁxed TBC (1%) and Mchit ¼ 0.25. In
a release experiment, 55.5 g of suspension containing the active atpH 5 was stirred in a 50 mL beaker on a magnetic plate. Small
(50e1000 mL) 10% NaOH aliquots were added in pH intervals up
from pH 5 to ca. pH 11. Only 2e3 mL of 10% NaOH in total was
required for this adjustment. When each pH interval had been
reached, a 1.5 mL aliquot was withdrawn from the suspension and
transferred to an Eppendorf tube. These withdrawn samples were
centrifuged (Sigma 3k30, SciQuip, UK) at 15,000 for 60 min and the
FSS concentration in the supernatant was determined, as per the EE
determination.
Due to its acid-base chemistry it was not possible to quantify FSS
concentration at low pH (i.e <pH 5); therefore, Rhod B was pref-
erentially used to monitor entrapment/release at pH < 5. For Rhod
B, the complex suspension was ﬁrst titrated down to pH 2 using
50e1000 mL aliquots of 10% HCl and then back up to pH ca. 11 with
50e1000 mL aliquots of 10% NaOH. 1.5 mL samples were taken in
intervals as described previously. FSS has an isosbestic point at
460 nm, which enabled its concentration to be obtained indepen-
dent of the pH change. Rhodamine B and riboﬂavin did not exhibit a
pH dependency on absorbance at the wavelengths employed for
their analysis in the UV-VIS spectrophotometer.
Release proﬁles are presented as %active released from the
complexes; the amount of active initially entrapped by the com-
plexes (CT  Ci,sup) at pH 5 was calculated by subtracting the initial
concentration of active in the supernatant (Ci,sup) after entrapment
at pH 5 from the total active concentration in the system (CT). %
active released was then calculated by measuring the additional
increase in active concentration in the supernatant as a function of
pH (Cf,sup  Ci,sup) divided by the initial concentration of active
entrapped (CT  Ci,sup):
% release ¼ Cf ; sup  Ci;sup
CT  Ci; sup
100 (5)
A schematic is presented in Fig. 1 to outline the general exper-
imental approach presented in this work.3. Results and discussion
3.1. Protein-chitosan complexing under low shear e inﬂuence of
protein type
Preliminary work focussed on comparing the complexing of
chitosan with two different proteins under low shear (i.e. magnetic
stirring). NaCAS and BSA were chosen as they adopt different
conformations in aqueous solution, with the former being an
unfolded protein and the latter a globular protein. Complexing of
chitosan with each protein was performed at pH 5, a condition
favouring associative phase separation (i.e. where individual
biopolymer charges were opposite). Few studies have investigated
complexation close to the IEP of the protein, and, at least for NaCAS,
this meant an initial suspension containing a signiﬁcant amount of
insoluble protein particles.
The ﬁrst part of the work considered the complexation of NaCAS
with chitosan at pH 5 under low shear magnetic stirring. At pH 5
NaCAS had amodest negative charge causing self-association of the
individual NaCAS molecules resulting in partial NaCAS phase sep-
aration. This was a consequence of the NaCAS solution pH being
close to the NaCAS' isoelectric point (IEP) (IEP of NACAS ~ 4.6
(Girard & Schaffer-Lequart, 2008)). Mixing NaCAS and chitosan
solutions under low shearwithin the region (TBC 0.25e2%) resulted
in associative phase separation caused by charge neutralisation
interactions occurring between chitosan and NaCAS. Visualisation
by light microscopy of these complexes revealed macro-sized,
irregular biopolymer complexes (see Fig. 2), and this particle
morphology was typical of complexes formed across the range of
Fig. 1. Schematic of experimental approach.
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TBCs (0.1e2%) investigated in this work. This demonstrated that
low shear mixing of NaCAS and chitosan solutions resulted in
macroscopic phase separation to produce inter-biopolymer pre-
cipitates. Such precipitates can be distinguished from coacervates,
as the latter are generally characterised as insoluble complexes (a
biopolymer rich phase) suspended as liquid droplets throughout aFig. 2. Representative light micrograph showing morphology of NaCAS-chitosan
complex precipitates formed under low shear. Mchit ¼ 0.25. TBC ¼ 1%. Scale
bar ¼ 100 mm. Comparable complex morphology was observed across the range of
biopolymer mixing ratios and total biopolymer concentrations investigated:
TBC ¼ 0.25e2% and Mchit ¼ 0.1e0.75.biopolymer depleted solvent continuous phase (Harnsilawat,
Pongsawatmanit, & McClements, 2006). However, the insoluble
complexes shown in Fig. 2 did not exhibit this deﬁning character-
istic and are therefore classiﬁed as precipitates.
Upon changing the protein type from NaCAS to BSA and mixing
the biopolymer solutions under equivalent solution (ionic strength,
TBC, pH) and processing conditions (low shear magnetic stirring),
the large-scale associative phase separation to produce precipitates
observed in the NaCAS-chitosan system was not apparent. Instead,
a single phase system comprising colloidal BSA-chitosan complexes
was observed. Further work also revealed that the complexes
formed between chitosan and BSA were transient and their pres-
ence strongly inﬂuenced by the BSA-to-chitosan mixing ratio. A
turbidity titration was employed to monitor BSA-chitosan particle
formation at pH 3, 5, and 6 (Fig. 3a); this approach is often used to
study particle formation during biopolymer complexing, as solu-
tion turbidity is related to particle size and concentration
(Weinbreck, de Vries, Schrooyen, & de Kruif, 2003).
Fig. 3a shows solution absorbance as a function of the
biopolymer mixing ratio (expressed as a function of chitosan con-
centration) at different pHs. At pH 3 where the net charge on both
BSA and chitosan was positive (the pH was below the pKa of chi-
tosan and also below the IEP of BSA), the electrostatic driving force
for biopolymer complexation was low, and the measured absor-
bance remained constant at baseline level across all the mass ratios
of BSA-to-chitosan measured. Under this condition it was probable
that the biopolymers' preferred thermodynamic state was co-
solubility: this was likely a consequence of each biopolymer
charge becoming positive, which reduced the electrostatic driving
force for association into biopolymer complexes.
Fig. 3. (a) turbidity titrations of BSA with chitosan at pH 3, 5, and 6. (b) absorbanceetime proﬁles of suspensions for titrations stopped at a chitosan concentration ¼ 0.05% and
periodically measured over time.
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became opposite, with chitosan possessing a net positive charge
and BSA a negative charge. Under this condition, as chitosan is
titrated into the BSA solution, particles form by biopolymer asso-
ciation and the solution turbidity increases. However, a key dif-
ference compared to the NaCAS-chitosan system was that only a
single phase system could be produced, which visually appeared
colloidal in nature (as opposed to demonstrating the large scale
phase separation observed for the NaCAS-chitosan system). This
suggested that the BSA-chitosan complexes formed had a higher
solubility than the NaCAS-chitosan particles described previously.
Beyond the absorbance maximum observed (in the region
0.01e0.05% chitosan), the turbidity then began to fall to baseline
level with further addition of chitosan (see Fig. 3a). This suggested
that the BSA-chitosan soluble particles had dissociated with
increasing chitosan concentration, leading to either co-soluble
biopolymers or soluble particles signiﬁcantly smaller than the
wavelength of the impinging light.
The stability of the BSA-chitosan soluble complexes was then
measured. To achieve this, the titration described previously was
stopped at a BSA-to-chitosan concentration ratio in the absorbance
maximum region (0.05% chitosan) (Fig. 3b). The resulting sample
was subsequently placed under quiescent storage at ambient
temperature and its absorbancemonitored over time. It can be seen
in Fig. 3b that the turbidity reduced over time upon storage of the
soluble complexes. This suggested that under the conditions of
particle formation employed in this work, the BSA-chitosan com-
plexes produced were only kinetically stable for 24e48 h, with a
tendency towards dissociation, i.e. the thermodynamically fav-
oured state under was either co-solubility of the biopolymers or
“rearrangement/break-up” into smaller particles. It should also be
noted that large experimental error did not allow for differences in
dissociation rates at pH 5 or 6 to be measured. The large error in
these experiments is probably due to microscopic inhomogeneity
in complex size and concentration distributed throughout the
samples, which could lead to differences in light scattering. The
process/mixing condition was reproduced as precisely and accu-
rately as possible; however, it was only possible to capture the
general trends as a function of pH. The BSA-chitosan complex
suspensions did not exhibit sedimentation, suggesting that
macroscopic phase separation was not the cause of the large error.
It has previously been stated that when the strength of the
interaction between the individual biopolymers is comparativelylarge, then insoluble complexes or coacervates form, whereaswhen
the interaction is weaker there is a tendency for the biopolymers to
be co-soluble or to form soluble complexes (Hong & McClements,
2007). From experiments presented in this paper it is clear that
protein structure has a major effect on the nature of the complexes
formed under comparable solution and processing conditions. It is
known that when biopolymers come into contact under pH con-
ditions favouring association they interact at junction zones
(Tolstoguzov, 2003). In the case of BSA-chitosan it is clear that these
junction zones were unstable, since the biopolymers dissociated
over short timescales. In contrast, the large interaction between
NaCAS and chitosan seemed to force macroscopic association into
insoluble biopolymer precipitates. For NaCAS-chitosan this may
have been driven to some extent by the fact the initial NaCAS so-
lution was at least partly phase separated (NaCAS showed some
phase separation at pH 5). Tolstoguzov has previously stated that
globular proteins cannot easily form contacts (junction zones) with
linear rod-like polysaccharides such as chitosan owing to topo-
logical limitations, which contrasts with proteins that are unfolded
such as casein, where the association interactions are greater
(Tolstoguzov, 2003). The results obtained in this work appear to
support this idea.
3.2. Ultrasound treatment of protein-chitosan precipitates
3.2.1. Production of colloidal NaCAS-chitosan insoluble complexes
Applications often require particles that remain stable to sedi-
mentation (i.e. are colloidal). The application of ultrasound on the
NaCAS-only and NaCAS-chitosan precipitates was thus investigated
as a route to reduce the particle size. Firstly, ultrasound to was
applied to a NaCAS-only suspension at pH 5 (the control). Without
chitosan being present in the formulation, the average particle
diameter did not reduce to the colloidal scale, and protein pre-
cipitates were observed even after sonication resulting from the
self-association of NaCAS close to its IEP. This is unsurprising since
dispersing protein particles (to a colloidal size) is a thermody-
namically unfavourable process and extremely difﬁcult to achieve
even using typical high energy processing options such as high
pressure homogenization or ultrasound treatment (Dickinson,
2012).
Applying ultrasound to the NaCAS-chitosan precipitates pro-
duced under low shear, demonstrated a noticeable change in bulk
suspension characteristics during sonication, depending primarily
Fig. 5. Cryo-SEM micrograph of the NaCAS-chitosan complexes/coacervates formed
after sonication of the preformed precipitates. Mchit ¼ 0.25. TBC ¼ 1%.
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resulting bulk suspensions were converted into colloidal suspen-
sions visually akin to typical oil-in-water emulsions. Fig. 4a shows
DLS analysis of these suspensions, with sub-micron z-average
particles sizes observed for Mchit  0.25. This suggested a coacer-
vate was formed upon the application of ultrasound to a NaCAS-
chitosan precipitate, as long as the biopolymer mixing ratio was
above a critical amount.
In terms of understanding the mechanism of coacervate for-
mation, it is useful to consider why application of ultrasound at
Mchit ¼ 0.1 did not produce a coacervate. At this biopolymer mixing
ratio the system remained macroscopically phase-separated with
sedimented, irregular precipitates observed at the bottom of the
sample vial, comparable in morphology to those shown in Fig. 2. It
should be noted that DLS is an inaccurate particle sizing tool for
particles produced at this mixing ratio (DLS is used for colloids
where Brownian motion dominates), although a particle size
measurement is reported in Fig. 4a with the correspondingly large
error to emphasize the difference. This was deemed viable for the
purposes of this work, as the trend was more important than
reporting of absolute average particle sizes.
This biopolymer mixing ratio dependence on whether sonicat-
ion could convert the precipitate into a coacervate suggested that
inter-complex forces had a major effect on the dispersive effect of
ultrasound in this system. Complexing of chitosan with NaCAS at
pH 5 caused charge neutralisation of oppositely charged chemical
groups present on NaCAS. NaCAS was at least partially phase
separated at pH 5 (prior to addition of chitosan) resulting from its
self-association into particles close to its IEP. When chitosan
physically interacts with NaCAS at pH 5 it introduced a cationic
charge repulsion between them. This cationic charge was probably
caused by excess amine groups that do not participate in protein
binding, thus conferring a cationic charge to the complex at pH 5.
As can be seen in Fig. 4b, a NaCAS-only suspension at pH 5 (without
chitosan present) possessed a modest zeta potential of 20 mV. It
has previously been observed across many systems that a zeta-
potential of at least ±30 mV is required to introduce enough elec-
trostatic repulsion to limit particle association (Heurtault, Saulnier,
Pech, Proust, & Benoit, 2003). Therefore, the magnitude of negative
charge observed in this work for a protein only slightly above its IEP
demonstrates why a high degree of association was observed. As
described previously, even sonication could not effectively disperse
these NaCAS particles.Fig. 4. (a) NaCAS-chitosan z-average complex diameter measured at pH 5 by DLS after ultras
(b) zeta-potentials measured after ultrasound at different NaCAS and chitosan mixing ratioAddition of increasing chitosan to these NaCAS suspensions
caused a charge reversal to limiting zeta potential of ca. 36 mV.
Fig. 4b shows that charge neutralisation (zeta potential ¼ 0) had
occurred at a biopolymer mixing ratio between 0 and 10% chitosan
(Mchit ¼ 0.1); however, even at Mchit ¼ 0.1, precipitates were
observed. It is probably that although charge neutralization had
been achieved, complete electrical coverage of the protein particles
had not been obtained. A likely consequence of this was that the
charge repulsion introduced between the complexes was insufﬁ-
cient to transfer the system from a precipitate to a coacervate (a
colloid) upon sonication. As chitosan was increased above 25% of
the total biopolymer concentration and in the limit of 75%, the zeta-
potential approached a limiting value of ca. 36 mV. It was probable
that complexes formed in this mixing region had sufﬁcient chitosan
present within them to provide effective charge repulsion between
the complexes, resulting in generation of a colloidal suspension on
application of ultrasound.
In order to compare the NaCAS-chitosan suspension after son-
ication (the coacervate) with the precipitates formed under low
shear (see Fig. 2), cryo-SEM (Fig. 5) was employed. This technique is
particularly versatile for this system as it enables structures to be
visualised in their native environment as opposed to after dry-
down where substantial structural changes are likely. Theound processing (2 min, 95% amplitude) at different NaCAS and chitosan mixing ratios.
s.
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complexes which appear to have contrasting morphologies than
complexes prepared under low shear (compare Fig. 2). In particular,
the complexes appeared spherical or near spherical as opposed to
irregular polymer clusters observed for the complexes prepared
under low shear. It is also clear that the particle size is signiﬁcantly
smaller than for the precipitates shown in Fig. 2, and this supports
the DLS measurements reported previously.3.2.2. Production of sub-micron BSA-chitosan complexes
As discussed previously, BSA formed transient soluble com-
plexes with chitosan under low shear mixing. However, in order to
generate structures with an encapsulation/delivery functionality, a
colloidal complex suspension (a coacervate) was preferred over a
complex precipitate. To increase the number of junction zones
available for chitosan and BSA to interact, thermal denaturation of
BSA was investigated. Heating globular BSA above its denaturation
temperature caused disruption of the intra-protein forces stabilis-
ing its higher order globular structure. The result of this process
was formation of insoluble protein aggregates driven by the hy-
drophobic effect. In this work, BSA denaturation in the presence of
chitosan was performed under equivalent solution (pH, ionic
strength, TBCs) and processing conditions (low shear magnetic
stirring) as for the NaCAS-chitosan system in order to provide a
direct comparison.
Heating a BSA-only solution (anywhere in the region 0.25e2%)
to 90 C followed by cooling to ambient temperature resulted in
protein phase separation, caused by BSA denaturation and a self-
association mechanism to form BSA particles. BSA exhibited large
scale phase separation and sedimented rapidly after heating, in a
similar fashion to NaCAS at pH 5. In a similar manner to NaCAS it
was observed that subjecting these BSA protein particles to soni-
cation could not disperse them to the colloidal scale. However,
performing the same denaturation process in the presence of chi-
tosan resulted in precipitate formation. In a similar manner as the
NaCAS-chitosan system, sonication could be employed to produce a
BSA-chitosan complex coacervate containing sub-micron com-
plexes. Again, the biopolymer mixing ratio strongly inﬂuenced
whether a colloidal suspension (a coacervate) could be produced
using ultrasound. Fig. 6a shows that a greater concentration of
chitosan within the suspension was required to produce a BSA-
chitosan complex coacervate than for the NaCAS system (see
Fig. 4a for comparison). A BSA-chitosan coacervate could be formedFig. 6. BSA-chitosan z-average particle diameter measured at pH 5 by DLS after ultrasou
different mixing ratios of BSA and chitosan. (b) zeta-potentials measured after ultrasoundat Mchit ¼ 0.75, whilst at the lower biopolymer mixing ratios the
suspension contained large scale precipitates. The visual appear-
ance in terms of its colloidal attributes of the BSA-chitosan sus-
pension at Mchit ¼ 0.75 was similar to the NaCAS-chitosan
suspensions at Mchit  0.25. These experiments suggested that as
BSA was denatured it transferred from a globular to unfolded
structure, which increased the number of junction zones available
for its interaction with chitosan; this was also in-line with obser-
vations made previously concerning complexation of BSA with
chitosan under ambient conditions.
The zeta-potential (Fig. 6b) data is also in-line with increased
chitosan necessary for providing effective charge repulsion in the
BSA-chitosan system: a zeta potential comparable to Mchit¼ 0.25 in
the NaCAS system was achieved when Mchit ¼ 0.75 in the BSA
system. This again demonstrated the importance of charge repul-
sive effects necessary for producing a colloidal suspension during
sonication. The fact that BSA required a higher concentration of
chitosan than NaCAS to generate a colloidal suspension was prob-
ably due to a difference in net interactions occurring between the
biopolymers, as inﬂuenced by protein molecular weight, amino
acid sequence, and conformation.3.3. Mechanistic considerations
To generalize some of the observations made previously, a
proposed mechanism is provided schematically in Fig. 7 and out-
lined below.
1. As chitosan is added to the protein under low shear it becomes
incorporated into the protein, interacting primarily by electro-
static interactionwith oppositely charged groups on the protein,
thus causing an increase in complex charge as observed via zeta
potential analysis. The conformation of the protein impacts
strongly on the extent of the interaction and hence the solubility
of the complexes produced.
2. When protein-chitosan precipitates have been formed under
low shear, subsequent application of ultrasound is strong
enough to disrupt intermolecular forces between the protein
particles but only under certain circumstances. When enough
chitosan is present during sonication, the protein particles
transfer from a bulk phase-separated precipitate to a colloidal
suspension (a coacervate). This is driven by the level of charge
repulsion introduced between the individual complexes.nd processing of the denatured BSA-chitosan precipitates (2 min, 95% amplitude) at
at different mixing ratios of BSA and chitosan.
Fig. 7. Mechanistic schematic of sub-micron complex/coacervate formation.
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ence of chitosan but at low concentration) after sonication is
that the anionic protein particles do not achieve full electrostatic
coverage with chitosan, therefore leaving charged patches on
surface of the protein particle; it is possible that this drives a
bridging interaction between the individual complexes (see
Fig. 7) resulting in their remaining in a precipitated state.3.4. Encapsulation and release studies
3.4.1. Encapsulation efﬁciency (EE)
Complexes (both precipitates and coacervates) fabricated in this
work were investigated for their use in encapsulation and pH
controlled release of model hydrophilic active compounds. Initial
work focussed on encapsulation of ﬂuorescein sodium salt (FSS),
with additional model compounds e rhodamine B (Rhod B) and
riboﬂavin (Ribo) e being employed to further investigate the
mechanisms involved. The main aim was to assess the interplay
between pH, encapsulation, and release, as pH is a useful triggering
mechanism relevant to food, pharmaceutical, and agrochemical
formulation design.
The ﬁrst experiments assessed the effect of different variables
on encapsulation efﬁciency (EE). The ratio of chitosan-to-protein
present (expressed as Mchit, where Mprotein ¼ 1  Mchit), TBC, pH,
and the effect of applying sonication were all studied.
Fig. 8 shows how Mchit and protein type inﬂuenced EE before
and after sonication for a ﬁxed TBC ¼ 1%. The ﬁrst point to make is
that the presence of chitosan was not required for encapsulation of
FSS in either system. FSS was encapsulated at pH 5 by both NaCAS-
and BSA-only (see Mchit ¼ 0). However, as discussed previously, the
presence of chitosan was necessary for forming a colloidal sus-
pension during sonication. Protein particles containing active
formed without chitosan present were phase separated protein
precipitates; this was true irrespective of whether this was driven
by denaturation (as for BSA) or by precipitation (as for NaCAS). The
resulting complexes, though possessing FSS encapsulation ability,had a low surface area for active transfer, in addition to sedimenting
rapidly resulting from the lack of colloidal stability. This made
forming complexes (as opposed to using the protein-only) advan-
tageous for molecular delivery.
The level of chitosan in the protein-chitosan complex suspen-
sions also inﬂuenced the magnitude of EE. As shown in Fig. 8, at
Mchit ¼ 0.75 the amount of FSS that was encapsulated decreased
signiﬁcantly. When chitosan was added above and beyond that
required for complete charge coverage of the protein, the zeta po-
tential approached a constant value indicating that additional
chitosan resided within the continuous phase (it did not form part
of the complex). This is evident in Fig. 4b, for example. Therefore
the reduction in EE could be attributed to competition between
encapsulation of FSS into the complexes versus binding into freely
soluble chitosan.
It was observed that sonication of the FSS-containing pre-
cipitates into coacervates did not reduce EE when chitosan was
present in the formulation; however, it did reduce it slightly for
both the protein-only cases. This suggested a different overall
mechanism of active binding between the protein-only and
protein-chitosan cases. It may be that the net interaction between
FSS and protein particle matrix was weaker than for FSS and the
protein-chitosan complex. However, additional experiments would
be required to conﬁrm this.
The fact that sonication did not dissociate FSS from the coacer-
vate matrix pointed to a strong (i.e. electrostatic) force holding the
active within its structure. This was further corroborated by Fig. 9
which shows how pH and TBC impact on FSS EE. At a pH favour-
ing complexation (i.e. pH 5), the EE increased from ca. 65%e90%
with increasing TBC. This TBC dependency on EE was to do with the
total amount of biopolymer available for encapsulating the active: a
higher biopolymer concentration meant more electrostatic binding
sites available and therefore higher EE for a ﬁxed active loading.
However, at pH 7 the driving force for complex formation was
reduced across all TBCs (i.e. the charge on chitosan was close to
zero). Under this condition, the electrostatic driving force for
assembling of the biopolymer complex with FSS was reduced,
Fig. 8. Encapsulation efﬁciency (EE) of FSS at pH 5 within (a) NaCAS-chitosan and (b) BSA-chitosan complexes before sonication (dotted bars) and after sonication (striped bars)
sonication. TBC was ﬁxed at 1%.
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tween the biopolymers and FSS. This could present itself as an
interaction between FSS and self-associated chitosan at pH 7 (the
pKa of chitosan ca. 6.5e7). The observed pH dependency on EE
reiterates the importance of the FSS-biopolymer matrix electro-
static interaction discussed earlier, which strongly inﬂuenced the
extent of FSS assembly with the biopolymer complex.
Two other actives (Rhod B and Ribo) were also tested for
encapsulation at pH 5. Rhod B was chosen since it has a similar
chemical structure, in terms of its aromatic acid group, to FSS (see
Table 1), whereas Ribo, a water-soluble vitamin, contrasts with FSS
and Rhod B in that it is a more basic molecule. Changing the active
structure gave additional understanding of which functional mol-
ecules might be suited for encapsulation in the biopolymer com-
plexes produced in this work.
Rhod B showed a similar EE to FSS (65%), whereas it was not
possible to encapsulate any Ribo under equivalent processing
conditions. As FSS and Rhod B are structurally similar (see Table 1),
both containing an aromatic acid group, it is probable that this
group participated via electrostatic interactionwith the biopolymerFig. 9. EE as a function of total biopolymer concentration (TBC) at pH 5 (closed
symbols) and pH 7 (open symbols). Biopolymer mixing ratio (as deﬁned by Mchit) was
ﬁxed at 0.25.matrix. The idea that the active acid group-complex matrix inter-
action drives encapsulation was strengthened on observation that
Ribo could not be encapsulated. Ribo does not possess the acid
chemical group and therefore cannot participate in electrostatic
intermolecular bonding. Thus, in general, chemical actives that
contain an organic acid group or other anionic group at pH 5 are
potential candidates for encapsulation in the protein-chitosan
biopolymer complexes produced in this work. This encompasses
actives across different sectors, including those found in pharma-
ceuticals, agrochemicals, and foods.
A ﬁnal feature of the complexes worth mentioning is that FSS
and Rhod B could also be loaded after complex formation, without
impacting signiﬁcantly on EE. This is an important process
consideration, as it is often undesirable to subject actives to high
energy processing operations such as high pressure homogenisa-
tion or sonication. Therefore, temperature or shear sensitive actives
could potentially be encapsulated after structure formation,
assuming they meet the other structural requirements. This in-
creases the utility of the complexes as well as improving process
ﬂexibility.3.4.2. Release of actives using a pH trigger
It is often desired to use an external trigger such as pH to
stimulate release of active ingredients from colloidal carriers. Such
materials are collectively known as ‘smart’ due to their ability to
respond to external stimuli. Active carriers fabrication in this
manner could be incorporated in various products to achieve a
desired effect (e.g. to target release or to protect the active). To this
end, the effect of pH on active release was examined. To achieve
this, complexes containing FSS and Rhod B were fabricated at pH 5
and subjected to different pH environments. Fig. 10 shows %active
(FSS and Rhod B) released from the NaCAS-chitosan coacervates as
a function of pH.
As the pH was increased from 5 to above the pKa of chitosan
(~6.5e7), the fraction of active released from the complexes
increased from less than 5% to 70e80%; this release behaviour was
consistent with a pH trigger release mechanism controlled by
electrostatic assembly of the complexes and the active.
Rhod B release was examined at pH < 5 to determine if these
complexes retained their payload under more acidic conditions.
Fig. 10 conﬁrmed that in the limit of pH 2, Rhod B release from the
biopolymer coacervate was negligible; the coacervate remained
intact at low pH with Rhod B residing within the sub-micron
Fig. 10. Release of ﬂuorescein (FSS) and Rhodamine B (Rhod B) from the fabricated
coacervates as a function of pH. TBC ¼ 1% and Mchit ¼ 0.25.
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amount released did not reach 100%, meaning that some of active
remained embedded within the dissociated biopolymers.
The release behaviour presented in Fig. 10 could prove useful in
a number of applications, including targeted release within the
human body. There is also potential for protecting acid-sensitive
actives from degradation within the acidic environment of the
human stomach, or for reducing stomach irritation. For food ap-
plications the structures would have to be formulated within acidic
products (pH 5e6) since this would be necessary for maintaining
complex stability. A key requirement of the active shown within
this work is that it had to form a strong interaction (electrostatic)
with the complex matrix. Since active release was inﬂuenced pri-
marily by pH dependent degradation/dissociation of the complex
and the electrostatic force holding the active within the particle
structuremeans sites could potentially be targetedwithout “losing”
active by diffusion to non-targeted sites. Overall, this has signiﬁcant
potential for the targeted release “tool-box”.4. Summary and conclusions
This work demonstrates the use of protein-chitosan complexes
for encapsulation and delivery of active compounds. The design
rules for colloidal suspension fabrication have been discussed ac-
counting for some of the key processing and formulation variables.
Factors inﬂuencing encapsulation of model actives have been
investigated, providing new insights for how these complexes
could be used for pH-modulated molecular delivery. It should be
noted that the functional molecules employed in this work are
model compounds for the ease of demonstrating the functionality
of the complexes; however, a next step would be to translate the
understanding for use with commercial functional ingredients.
A key advantage of colloidal suspensions produced in this work
is that they can be produced via currently used processing tech-
nologies, making them useful to have in the formulation tool-box.
An additional processing step might be to include a drying step
to yield a powdered product, which may be preferable for some
commercial applications.
A next step would be to evaluate these structures for translation
into food, pharmaceutical, and agrochemical products, both in
terms of how they inﬂuence active/nutrient delivery (e.g.
bioavailability and/or bioactivity) but also with respect to their bulkmaterial properties (e.g. rheology). The rheology of the coacervate
suspensions would in particular be an interesting consideration
since the complex suspensions (mixed biopolymer systems) appear
qualitatively to have similar rheological properties to typical oil-in-
water emulsions.
As chitosan is muco-adhesive it would also be beneﬁcial to
evaluate how this property is inﬂuenced by the presence of the
protein, as well as how this could potentially inﬂuence active/
nutrient bio-availability, bio-activity, and bio-efﬁcacy in food,
pharmaceutical, and agrochemical molecular delivery.Acknowledgements
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